Natco Pharma invests Rs 120 crore in Visakhapatnam facility: Report

19 Nov 2016 Evaluate

Natco Pharma is reportedly planning to double the drug filings from the next financial year on the back of additional formulations capacity. The company is investing Rs 120 crore in the Visakhapatnam facility, which will be its first plant in Andhra Pradesh and it's new formulations manufacturing facility in Visakhapatnam is likely to be completed by 2017. 

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×